The IOM published report, “Future of Nursing: Leading Change, Advancing Health,” makes recommendations for lifelong learning and achieving higher levels of education.

In 1,000-1,250 words, examine the importance of nursing education and discuss your overall educational goals.

Include the following:

1. Discuss your options in the job market based on your educational level.
2. Review the IOM Future of Nursing Recommendations for achieving higher levels of education. Describe what professional certification and advanced degrees (CRNA) you want to pursue and explain your reasons for wanting to attain the education. Discuss your timeline for accomplishing these goals.
3. Discuss how increasing your level of education would affect how your competitiveness in the current job market and your role in the future of nursing.
4. Discuss the relationship of continuing nursing education to competency, attitudes, knowledge, and the ANA Scope and Standards for Practice and Code of Ethics.
5. Discuss whether continuing nursing education should be mandatory. Provide support for your response.

You are required to cite to a minimum of three sources to complete this assignment. Sources must be published within the last 5 years and appropriate for the assignment criteria and relevant to nursing practice.  

  

Imagine that you’re a new medical assistant who is visiting with a patient, Freya House. She is a 16-year-old female complaining of unexplained weight loss, inability to sleep, shortness of breath, and nervousness. She was diagnosed with sickle cell anemia as a child and has been receiving treatment of hydroxyurea for the past 10 years. As an up-and-coming medical assistant, it is important for you to understand how this disease can impact her body and what treatments she will likely need.

For this discussion, select at least one symptom that she is experiencing and describe whether her sickle cell anemia could be a cause of this symptom. How could this impact her organs, ability to fight infections, blood vessels, or blood cells?

 PLEASE I NEED RESPONSE TO THIS ASSIGNMENT

2 REFERENCES

A major neurocognitive disorder is used to describe a decline in cognitive function characterized by gradual impairment in memory, speech, mobility, and reasoning. The impairment in mental ability could be severe to the extent of affecting independence and ability to carry out daily/ normal activities (Caccappolo & Marder, 2015).

Diagnostic Criteria

 According to the DSM-5, the diagnostic criterion for major neurocognitive disorder includes a very gradual (“insidious”) onset, and gradual progression. Additionally, the clinical features suggestive of neurocognitive disorder with Lewy bodies are divided into three core diagnostic features, and two suggestive diagnostic features. The core diagnostic features are as follows:

1. Fluctuating cognition including marked variability in attention and alertness.

2. Recurrent, well-formed, and detailed visual hallucinations.

3. Presence of “spontaneous” parkinsonism (i.e., not due to medication side effects) that started AFTER onset of the cognitive decline.

The two suggestive diagnostic features are as follows:

1. Rapid eye movement sleep behavior disorder.

2. Marked sensitivity to side effects of antipsychotic medications.

Furthermore, the diagnosis of neurocognitive disorder (major or mild) with Lewy bodies can be probable or possible. The difference between a probable diagnosis and a possible diagnosis of neurocognitive disorder with Lewy bodies is in what clinical features are present. A probable diagnosis consists of either two core features OR at least one core feature plus at least one suggestive feature. A possible diagnosis consists of one core feature OR one or more suggestive features (American Psychiatric Association, 2013).

Evidenced-Based Psychotherapy and Psychopharmacologic Treatment

As far as psychotherapy is concerned, there is a lack of research concerning non-pharmacological interventions for Lewy Body Dementia (Livingston et al., 2014). Lewy Body Dementia (LBD) is characterized by a deficiency of acetylcholine and a deficiency of dopamine. The cholinergic deficit is implicated in major attention disorders and fluctuations. Acetylcholinesterase inhibitors such as donepezil or rivastigmine were studied in several double-blind placebo-controlled studies (Rolinski et al., 2016). There was moderate benefit on the cognitive level and on some psychiatric manifestations including hallucinations. A disabling parkinsonian syndrome can be treated with L-dopa as in Parkinson’s disease. Hallucinations may require antipsychotic treatment and the best documented drug is clozapine (Rolinski et al., 2016). REM sleep behavior disorders can be improved by melatonin.

Therapy Types and Risks  

 Because antipsychotic drugs can worsen Lewy body dementia symptoms, the best we can do to help limit this is modifying the environment. Reducing clutter and distracting noise can make it easier for someone with dementia to function. Offering reassurance and validation of their concerns especially when they are confused. And finally creating daily routines and keeping tasks simple. There are no risks involved in implementing theses therapies.

References

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.

Caccappolo, E., & Marder, K. (2015). Epidemiology, diagnosis, and correlates of mild cognitive impairment in Parkinson’s disease. Cognitive Impairment and Dementia in Parkinson’s Disease, 203–222. https://doi.org/10.1093/med/9780199681648.003.0016

Connors, M. H., Quinto, L., McKeith, I., Brodaty, H., Allan, L., Bamford, C., Thomas, A., Taylor, J.-P., & O’Brien, J. T. (2018). Non-pharmacological interventions for Lewy body dementia: a systematic review. Psychological Medicine, 48(11), 1749–1758. https://doi-org.ezp.waldenulibrary.org/10.1017/S0033291717003257

Livingston, G., Kelly, L., Lewis-Holmes, E., Baio, G., Morris, S., Patel, N., Omar, R. Z., Katona, C., & Cooper, C. (2014). Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials. The British Journal of Psychiatry, 205(6), 436–442.

Rolinski, M., Fox, C., Maidment, I., McShane, R., & Rolinski, M. (2016). Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease. Cochrane Database of Systematic Reviews, 3.

There is often the requirement to evaluate descriptive statistics for data within the organization or for health care information. Every year the National Cancer Institute collects and publishes data based on patient demographics. Understanding differences between the groups based upon the collected data often informs health care professionals towards research, treatment options, or patient education.

Using the data on the “National Cancer Institute Data” Excel spreadsheet, calculate the descriptive statistics indicated below for each of the Race/Ethnicity groups. Refer to your textbook and the Topic Materials, as needed, for assistance in with creating Excel formulas.

Provide the following descriptive statistics:

1. Measures of Central Tendency: Mean, Median, and Mode
2. Measures of Variation: Variance, Standard Deviation, and Range (a formula is not needed for Range).
3. Once the data is calculated, provide a 150-250 word analysis of the descriptive statistics on the spreadsheet. This should include differences and health outcomes between groups.

APA style is not required, but solid academic writing is expected.

This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion. 

You are not required to submit this assignment to LopesWrite.